(19)

(11)

EP 3 794 098 A1

(12)

(43) Date of publication: 24.03.2021 Bulletin 2021/12 (21) Application number: 19803903.4 (22) Date of filing: 15.05.2019

(51) International Patent Classification (IPC):  C11B 11/00(2006.01) A61K 31/683(2006.01) C11B 1/10(2006.01) A23J 7/00(2006.01) A61K 47/44(2017.01) C11B 3/00(2006.01) (86) International application number: PCT/CA2019/050651 (87) International publication number: WO 2019/218062 (21.11.2019 Gazette 2019/47)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 16.05.2018 US 201862672180 P (71) Applicant: Acasti Pharma, Inc. Laval, Quebec H7T 0A3 (CA)	(72) Inventors: LEMIEUX, Pierre Laval, Québec H7T 0B3 (CA) DESPINS, Simon Laval, Québec H7T 0B3 (CA) AZIZ, Sarya Laval, Québec H7T 0B3 (CA) LABRECQUE, Remi Laval, Québec H7T 0B3 (CA) BISSUEL, Nicolas Laval, Québec H7T 0B3 (CA) (74) Representative: Regimbeau  20, rue de Chazelles 75847 Paris Cedex 17 75847 Paris Cedex 17 (FR)